Correspondence 0001121702-24-000057 from YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)

YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)
Date: July 22, 2024 · CIK: 0001121702 · Accession: 0001121702-24-000057

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-278930

Date

July 22, 2024

Author

Form

CORRESP

Company

YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)

Letter

VIA EDGAR Yield10 Bioscience, Inc. (the "Company") Registration Statement on Form S-1, as amended (the "Registration Statement") File No. 333-278930

Re:

Dear Mr. O'Leary:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on July 24, 2024, or as soon as practicable thereafter. The Company’s common stock is currently traded on the over-the-counter market and quoted on the OTC QB market under the symbol “YTEN” https://www.otcmarkets.com/stock/YTEN/overview).

Please contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

Respectfully,
Yield10 Bioscience, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Document

Yield10 Bioscience, Inc.
19 Presidential Way
Woburn, Massachusetts 01801

July 22, 2024

VIA EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attn: Nicholas O'Leary

  Re:

  Yield10 Bioscience, Inc. (the "Company")

    Registration Statement on Form S-1, as amended (the "Registration Statement")

    File No. 333-278930

Dear Mr. O'Leary:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on July 24, 2024, or as soon as practicable thereafter.  The Company’s common stock is currently traded on the over-the-counter market and quoted on the OTC QB market under the symbol “YTEN” https://www.otcmarkets.com/stock/YTEN/overview).

Please contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this request.  In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

  Respectfully,

  Yield10 Bioscience, Inc.

 By:

 /s/ Oliver P. Peoples

 Name: Oliver P. Peoples

 Title: President and Chief Executive Officer

cc:    Megan Gates, Covington & Burling LLP

SecProbe.io